Question explored with the scientific record
Conversation so far
- 1 what make nitrous oxide decrease as we get older, what are the effect, what are the solutions
- 2 what do we know about nitric oxide, what help, what is antagonist, what are the medication that could help increase it, what are the effects
Answered on this page ↓
what do we know about nitric oxide, what help, what is antagonist, what are the medication that could help increase it, what are the effects
The short version: nitric oxide is a master signaling molecule that keeps blood vessels open and blood flowing, and aging reliably degrades it through oxidative stress and loss of its helper molecule BH4.
Nitric oxide is made by endothelial cells lining your blood vessels. It relaxes vessel walls, lowers blood pressure, keeps platelets from clumping, and supports oxygen delivery to tissues. Its main job is to activate an enzyme called soluble guanylate cyclase, which raises cGMP and relaxes smooth muscle [12, 13]. When NO is working, blood flows well. When it drops, vessels stiffen, blood sludges, and organs starve for oxygen.
Aging hits NO through several mechanisms. Oxidative stress is the biggest one. Superoxide radicals scavenge NO directly and also oxidize BH4, the cofactor that keeps NO synthase functioning properly [2, 9]. When BH4 runs low, the enzyme stops making NO and starts making superoxide instead—a vicious cycle called eNOS uncoupling [9, 11]. In aged rats, BH4 content dropped by roughly 60% and flow-mediated vasodilation fell by half [2]. In older humans, plasma nitrite (a NO breakdown product) fell from about 140 to 117 µmol/L in healthy older adults, and to 103 in frail ones, while oxidative stress markers rose fivefold [6]. Angiotensin II, which rises with age, also drives NADPH oxidase to produce superoxide and suppresses NO signaling [8].
The antagonists of NO are oxidative stress, inflammation, and oxidized cholesterol. Hydrogen peroxide and superoxide both uncouple eNOS and destroy NO [11]. The oxidized cholesterol 25-hydroxycholesterol directly inhibits eNOS and promotes endothelial cell death [10]. Inflammation, even a mild vaccine-induced inflammatory response, measurably reduces NO bioavailability within hours [4]. Depression and chronic stress activate NF-κB, which also suppresses NO [7].
What raises NO? Exercise and genistein (a soy isoflavone) restored NO production in aged rats from about 35% to 77-81% of young levels [1]. Calorie restriction in old mice reversed endothelial dysfunction by restoring NO and cutting superoxide [3]. Dietary inorganic nitrate—from beets and leafy greens—improves metabolic syndrome features even in mice lacking eNOS entirely, because bacteria in your mouth and gut convert nitrate to nitrite to NO through a backup pathway [5]. BH4 supplementation or its salvage pathway (sepiapterin) restores eNOS coupling [9, 11]. Salsalate, an anti-inflammatory, improved acetylcholine-induced vasodilation in depressed adults from 67% to 87% by suppressing NF-κB [7].
| Intervention | Effect on NO system | Population studied |
|---|---|---|
| Exercise | NO production 38% → 81% of young | Aged rats [1] |
| Genistein | NO production 35% → 77% of young | Aged rats [1] |
| Calorie restriction | Restored NO, cut superoxide 150% → normal | Old mice [3] |
| Dietary nitrate | Restored NO signaling without eNOS | eNOS-knockout mice [5] |
| BH4/sepiapterin | Re-coupled eNOS, cut superoxide | Mice, cell models [9, 11] |
| Salsalate | Vasodilation 67% → 87% | Depressed adults [7] |
Drugs that boost NO include nitroglycerin and other nitrate donors, which release NO directly. PDE5 inhibitors like sildenafil work downstream by preventing cGMP breakdown. sGC stimulators like riociguat activate the enzyme directly even when NO is low [13, 14]. These are prescription drugs with real side effects—headaches, hypotension—and they treat symptoms rather than the root cause. The root cause is oxidative stress and BH4 depletion, which is why lifestyle interventions and antioxidants address the mechanism while drugs only bypass it.
My call: aging degrades NO primarily through oxidative stress and BH4 loss, and the best-evidenced solutions are exercise, calorie control, dietary nitrate, and antioxidant support—drugs are downstream patches. Confidence: moderate.
Sources used 14
-
Increased NO bioavailability in aging male rats by genistein and exercise training: using 4, 5-diaminofluorescein diacetate
In aged male rats, genistein and endurance exercise were evaluated for their ability to counter age-related endothelial dysfunction by enhancing nitric oxide (NO) bioavailability in cremasteric microvessels, with both interventions improving Ach-induced vasodilation, increasing …
DOI: 10.1186/1477-7827-7-93 -
Ageing diminishes endothelium‐dependent vasodilatation and tetrahydrobiopterin content in rat skeletal muscle arterioles
This study investigates how aging affects endothelium-dependent vasodilatation in rat skeletal muscle arterioles, revealing that reduced tetrahydrobiopterin (BH4) bioavailability, rather than increased arginase activity, contributes to the impairment of nitric oxide signaling as…
DOI: 10.1113/jphysiol.2007.147686 -
Short‐term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress
This study demonstrates that short-term calorie restriction initiated late in life can reverse vascular endothelial dysfunction in old mice by increasing nitric oxide bioavailability and reducing oxidative stress.
DOI: 10.1111/j.1474-9726.2010.00557.x -
Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress
This study investigates the mechanisms of inflammation-induced endothelial dysfunction in humans, demonstrating that typhoid vaccination leads to reduced nitric oxide bioavailability and increased oxidative stress, which can be partially reversed by antioxidant supplementation.
DOI: 10.1016/j.cardiores.2004.06.020 -
Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice
This study demonstrates that dietary supplementation with inorganic nitrate can reverse features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice by enhancing bioavailable nitric oxide levels.
DOI: 10.1073/pnas.1008872107 -
Endothelial-Mediated Vascular Function in Frail Older Adults: A Pilot Study
Endothelial function declines with aging, frailty, and obesity in older adults, as evidenced by reduced FMD and PLM-induced hyperemia and by decreased NO bioavailability with increased oxidative stress.
DOI: 10.1093/geroni/igaf122.3578 -
675. Nuclear Factor-ΚB Activation Contributes to Vascular Endothelial Dysfunction in Adults with Major Depressive Disorder
This study investigates the role of nuclear factor-κB (NF-κB) activation in contributing to endothelial dysfunction in adults with Major Depressive Disorder (MDD), revealing that systemic inflammation reduces vascular nitric oxide bioavailability.
DOI: 10.1016/j.biopsych.2017.02.1084 -
Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling
This study investigates the effects of angiotensin II infusion on endothelial dysfunction, highlighting the role of NAD(P)H oxidase and nitric oxide synthase III in vascular superoxide production and signaling pathways.
DOI: 10.1161/01.res.0000012569.55432.02 -
Tetrahydrobiopterin Deficiency and Nitric Oxide Synthase Uncoupling Contribute to Atherosclerosis Induced by Disturbed Flow
This study investigates the role of tetrahydrobiopterin (BH4) deficiency and nitric oxide synthase (NOS) uncoupling in the development of atherosclerosis induced by disturbed blood flow, demonstrating that BH4 treatment can prevent endothelial dysfunction and atherosclerosis in …
DOI: 10.1161/atvbaha.111.226456 -
25-Hydroxycholesterol impairs endothelial function and vasodilation by uncoupling and inhibiting endothelial nitric oxide synthase
25-Hydroxycholesterol impairs endothelial function and vasodilation by uncoupling and inhibiting endothelial nitric oxide synthase (eNOS), promoting endothelial apoptosis, and thereby potentially contributing to atherogenesis.
DOI: 10.1152/ajpendo.00218.2016 -
Mechanisms of H2O2-induced oxidative stress in endothelial cells
The study shows that high levels of hydrogen peroxide induce oxidative stress and cytotoxicity in porcine aortic endothelial cells by increasing intracellular superoxide through both NOS uncoupling and NADPH oxidase activation, with MnSOD overexpression and pharmacological inhib…
DOI: 10.1016/j.freeradbiomed.2006.02.017 -
Spectral and Kinetic Studies on the Activation of Soluble Guanylate Cyclase by Nitric Oxide
This study investigates the activation mechanism of soluble guanylate cyclase (sGC) by nitric oxide (NO), demonstrating that NO binds to the heme of sGC to form a 6-coordinate nitrosyl complex that converts to a 5-coordinate nitrosyl complex, significantly enhancing enzyme activ…
DOI: 10.1021/bi9519718 -
Wedging open a catalytic site
A cryo-EM and SAXS study reveals how nitric oxide activates soluble guanylate cyclase by rearranging the HNOX, PAS, and coiled‑coil domains to open the catalytic pocket, and shows YC-1–like stimulators wedge into the rearranged site to stabilize the active conformation, illumina…
DOI: 10.7554/elife.52418 -
Nitric Oxide Resistance Reduces Arteriovenous Fistula Maturation in Chronic Kidney Disease in Rats
This study investigates the impact of chronic kidney disease (CKD) on the maturation of arteriovenous fistulas in rats, revealing that CKD leads to nitric oxide resistance and impaired vascular adaptation, which can be partially mitigated by the soluble guanylate cyclase activat…
DOI: 10.1371/journal.pone.0146212